NCBiotech News

We work hard to bring you the stories about the life science community in North Carolina. Every once in a while, we add a little news of our own. Read some of those stories below, or check out some of our perspectives on our staff blog.

Humacyte, a regenerative medicine company based in Morrisville, has launched a Phase 2 clinical trial of Humacyl, its bioengineered blood vessel, in patients with peripheral arterial disease.

RAUMEDIC, a family-owned German company, is nearing its first anniversary at its $27 million development and production facility in western North Carolina.

Research Triangle Park–based curasan Inc. is poised for growth in 2017, thanks to an important December 2016 milestone for its synthetic bone regeneration material CERASORB Ortho FOAM.

TransEnterix, a Morrisville-based medical device company that uses robotics to improve minimally invasive surgery, has opened a new European training and research and development center in Milan, Italy.

By Barry Teater, NCBiotech Writer

A new National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) will have a strong North Carolina flavor when it starts work in March 2017.

“North Carolina is one of the leading states in biopharmaceutical manufacturing, and we will play a key role in NIIMBL efforts,” said Ruben G. Carbonell, Ph.D., a professor at N.C. State University (NCSU) who will be the consortium’s chief technology officer. “This is a fantastic opportunity for North Carolina.

Two years after announcing plans for a yeast production facility in Asheville, West Coast fermentation specialty company White Labs is about to start “Yeast Coast” production at its new factory in January 2017.

TyraTech, a small Morrisville company, has parlayed a simple observation made in a cancer research lab into a growing business of controlling insects and parasites without the use of synthetic pesticides.

Bioscience briefs with names making news

North Carolina’s life science sector registered another year of robust growth in 2016 with deals that will create capital ​investment and high-paying jobs well into the future. Here are some of the year's highlights.

North Carolina’s world-leading contract research industry got another boost today when INC Research announced plans to move its global headquarters from Raleigh to nearby Morrisville and add 550 jobs over five years.

G1 Therapeutics, a clinical-stage oncology company based in Research Triangle Park, will team up with biotech pioneer Genentech on a cancer clinical trial in the new year.

East Carolina University, First Flight Venture Center in RTP and the Durham-based Investors’ Circle have received federal grants to help promote entrepreneurship development programs.

Twenty-nine small companies – most of them in the biosciences – received grants totaling $1.7 million from the One North Carolina Small Business Program in the latest quarter ending Oct. 30.

First Flight Venture Center (FFVC), a Research Triangle Park science and technology incubator for entrepreneurs, has been awarded a $450,000 challenge grant from the U.S. Department of Commerce.

FFVC was among 36 organizations, selected from a pool of more than 215 applicants, to receive a total of $15 million from the federal Regional Innovation Strategies (RIS) program.

A new Wilmington company, Optima BioEnergy, is aiming to capture renewable natural gas from swine manure that would otherwise decay and pollute the atmosphere with greenhouse gases.